LMCQX
Price
$32.86
Change
+$0.01 (+0.03%)
Updated
Aug 28 closing price
Net Assets
1.12B
MVCAX
Price
$32.34
Change
-$0.05 (-0.15%)
Updated
Aug 28 closing price
Net Assets
17.32B
Interact to see
Advertisement

LMCQX vs MVCAX

Header iconLMCQX vs MVCAX Comparison
Open Charts LMCQX vs MVCAXBanner chart's image
Lord Abbett Mid Cap Stock R2
Price$32.86
Change+$0.01 (+0.03%)
VolumeN/A
Net Assets1.12B
MFS Mid Cap Value A
Price$32.34
Change-$0.05 (-0.15%)
VolumeN/A
Net Assets17.32B
LMCQX vs MVCAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LMCQX vs. MVCAX commentary
Aug 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LMCQX is a Buy and MVCAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MVCAX has more cash in the bank: 17.3B vs. LMCQX (1.12B). MVCAX pays higher dividends than LMCQX: MVCAX (0.86) vs LMCQX (0.24). LMCQX was incepted earlier than MVCAX: LMCQX (17 years) vs MVCAX (24 years). LMCQX (1.38) is less costly to investors than MVCAX (1.00). LMCQX is a more actively managed with annual turnover of: 53.00 vs. MVCAX (27.00). LMCQX has a lower initial minimum investment than MVCAX: LMCQX (0) vs MVCAX (1000). MVCAX annual gain was more profitable for investors over the last year : -3.51 vs. LMCQX (-7.79). MVCAX return over 5 years is better than : 50.80 vs. LMCQX (34.88).
LMCQXMVCAXLMCQX / MVCAX
Total Expense Ratio1.380.99139%
Annual Report Gross Expense Ratio1.381.00138%
Fund Existence17 years24 years-
Gain YTD-0.6055.574-11%
Front LoadN/A6%-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.12B17.3B6%
Annual Yield % from dividends0.240.8628%
Returns for 1 year-7.79-3.51222%
Returns for 3 years12.6214.9884%
Returns for 5 years34.8850.8069%
Returns for 10 years36.0375.5048%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NGENF2.700.29
+11.99%
NervGen Pharma Corp.
PRRFY13.03N/A
N/A
Premier Foods Plc.
ALEGF7.65N/A
N/A
ALLEGRO EU SA
RVXCF0.07N/A
N/A
Resverlogix Corp.
BKFAF7.01N/A
N/A
BROOKFIELD CORP.